Bristol-Myers raises buyout offer for ImClone to $4.7 billion

09/22/2008 | Forbes

Bristol-Myers Squibb announced that it is increasing its takeover offer for ImClone Systems to $62 per share, raising the value of the deal to $4.7 billion. In a letter to ImClone Chairman Carl Icahn, Bristol-Myers Chairman and CEO James Cornelius said delays in the transaction "have created a protracted period of uncertainty among our stockholders, employees and other constituents."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ